PMID: 6105394Aug 2, 1980Paper

Renal clearance of pentavalent antimony (sodium stibogluconate)

Lancet
P H ReesW T Hockmeyer

Abstract

Kenyan kala-azar is sometimes unresponsive to a standard course of sodium stibogluconate. The renal excretion of sodium stibogluconate was therefore studied in patients with kala azar and in volunteers; both urine and serum levels of sodium stibogluconate were measured. After intravenous injection sodium stibogluconate seemed to be distributed throughout the extracellular fluid and to have a renal clearance similar to that of inulin. At 6 h blood levels had fallen to less than 1% of peak values. After intramuscular injection, peak blood levels were lower and more sustained. However, more than 80% was excreted in the first 6 h, and blood levels fell to around 1% of peak values in 16 h. The dangers of cumulative toxicity may be exaggerated, and restriction of courses of sodium stibogluconate to 30 days or even to 10 days (in the U.S.A.) may not be necessary. If shorter courses are ineffective prolonged and continued courses may be given provided that renal function is assessed and the dosage is adjusted when indicated.

References

Jan 1, 1977·Transactions of the Royal Society of Tropical Medicine and Hygiene·C D BlackR J Ward
Jan 1, 1981·Transactions of the Royal Society of Tropical Medicine and Hygiene·W T HockmeyerL D Hendricks
Mar 1, 1959·Transactions of the Royal Society of Tropical Medicine and Hygiene·P E MANSON-BAHR
Oct 1, 1945·Transactions of the Royal Society of Tropical Medicine and Hygiene·L G GOODWIN

❮ Previous
Next ❯

Citations

Jan 1, 1993·International Archives of Occupational and Environmental Health·P O Droz
May 28, 2011·Biological Trace Element Research·Claus HansenStefan Stürup
Feb 22, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·J G DoreaJ Holzbecher
Jan 1, 1981·Transactions of the Royal Society of Tropical Medicine and Hygiene·P A KagerW H Lyerly
Jan 1, 1985·Transactions of the Royal Society of Tropical Medicine and Hygiene·A D BrycesonH C Spencer
Jan 1, 1986·Transactions of the Royal Society of Tropical Medicine and Hygiene·C P Thakur
Jan 1, 1987·Transactions of the Royal Society of Tropical Medicine and Hygiene·D O FreedmanJ B Viloria
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·J D ChulayD H Smith
Nov 1, 1989·Transactions of the Royal Society of Tropical Medicine and Hygiene·J D BermanF A Neva
Mar 1, 1990·Transactions of the Royal Society of Tropical Medicine and Hygiene·C N ChungeL Donno
Sep 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·M Balzan, F Fenech
Mar 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·R N Davidson, S L Croft
May 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·S TeklemariamA Bryceson
Feb 4, 1998·Chemico-biological Interactions·T Gebel
Feb 1, 1981·The Journal of Experimental Medicine·G S Drummond, A Kappas
Jun 12, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Keke FanTaolin Yi
Mar 1, 1994·International Journal of Dermatology·V Ramesh
Sep 1, 1993·The Journal of Pharmacy and Pharmacology·K C CarterJ Alexander
Oct 10, 1987·British Medical Journal·C P ThakurA K Pandey
Dec 2, 2011·Journal of Toxicology and Environmental Health. Part a·Karen FriedrichFrancisco J R Paumgartten
Apr 2, 2003·Fundamental & Clinical Pharmacology·Philippe MinodierJean-Marc Garnier
Jan 26, 2005·Annals of Tropical Medicine and Parasitology·I Y Zaghloul, M Al-Jasser
Jan 1, 1993·Journal of Drug Targeting·M CollinsJ O'Grady
Oct 30, 2010·Expert Opinion on Drug Delivery·Frédéric Frézard, Cynthia Demicheli
Aug 7, 1999·Revista Do Instituto De Medicina Tropical De São Paulo·M L RodriguesA M Roselino
May 17, 2005·Revista Da Sociedade Brasileira De Medicina Tropical·Armando de Oliveira SchubachMauro Célio de Almeida Marzochi
Jul 1, 1990·Revista Do Instituto De Medicina Tropical De São Paulo·J P VeigaP D Marsden
Nov 10, 2004·Acta Tropica·J C MachariaM M Gicheru
Sep 1, 1992·Medicinal Research Reviews·J C KatiyarS Sharma
May 24, 2007·The Journal of Dermatological Treatment·Vikram K Mahajan, Nand Lal Sharma
Dec 16, 1998·Therapeutic Drug Monitoring·J M Reymond, J Desmeules
Nov 1, 1985·Revista Do Instituto De Medicina Tropical De São Paulo·J P VeigaP D Marsden
Dec 1, 1995·Annals of Tropical Medicine and Parasitology·M L Chance
Aug 2, 2017·Clinical Pharmacokinetics·Anke E KipThomas P C Dorlo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.